tiprankstipranks
MediNet Group Ltd. (HK:8161)
:8161
Hong Kong Market

MediNet Group Ltd. (8161) AI Stock Analysis

0 Followers

Top Page

HK:8161

MediNet Group Ltd.

(8161)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
HK$0.55
▼(-8.67% Downside)
Action:ReiteratedDate:03/24/26
The score is primarily constrained by mixed financial quality: while FY2025 profitability and cash conversion improved, revenue is declining and leverage has risen sharply with debt exceeding equity. Technicals add modest support with neutral-to-mildly positive momentum. Valuation is a headwind due to a negative P/E and no dividend yield data.
Positive Factors
Diversified service and client mix
A broad offering across medical and dental services plus corporate health packages and insurer partnerships creates durable, recurring revenue channels. This multi-client model supports cross-selling, steady utilization, and exposure to corporate contracts that tend to be longer‑dated and stickier than retail visits.
Negative Factors
Declining revenue trend
A pronounced revenue decline undermines the sustainability of the recent profit rebound because margins can be volatile with lower volumes. Persistent top‑line weakness constrains pricing power, makes cross‑selling harder, and increases dependency on cost cuts to preserve earnings over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified service and client mix
A broad offering across medical and dental services plus corporate health packages and insurer partnerships creates durable, recurring revenue channels. This multi-client model supports cross-selling, steady utilization, and exposure to corporate contracts that tend to be longer‑dated and stickier than retail visits.
Read all positive factors

MediNet Group Ltd. (8161) vs. iShares MSCI Hong Kong ETF (EWH)

MediNet Group Ltd. Business Overview & Revenue Model

Company Description
MediNet Group Limited, an investment holding company, provides medical and dental solutions to corporates, insurance companies, and individuals in Hong Kong and the People's Republic of China. It operates two MediNet Centres that offer a range of ...

MediNet Group Ltd. Financial Statement Overview

Summary
FY2025 shows a meaningful profitability rebound and improved cash conversion, but revenue declined and results have been volatile over multiple years. Balance-sheet risk is elevated as leverage increased materially with debt exceeding equity, and operating cash flow remains modest relative to the debt load.
Income Statement
62
Positive
Balance Sheet
45
Neutral
Cash Flow
58
Neutral
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue116.15M106.39M116.25M110.39M121.07M129.48M
Gross Profit14.71M55.16M15.20M56.68M65.44M70.55M
EBITDA3.76M17.54M2.39M-11.60M8.06M20.10M
Net Income13.44M8.06M-8.08M-24.88M-6.22M4.75M
Balance Sheet
Total Assets42.51M51.65M42.03M42.88M68.46M75.89M
Cash, Cash Equivalents and Short-Term Investments11.16M13.87M17.32M15.57M15.60M20.65M
Total Debt15.10M18.11M15.96M9.82M12.85M14.25M
Total Liabilities31.39M40.50M38.84M31.55M31.82M32.84M
Stockholders Equity11.58M11.60M3.63M11.76M36.80M43.05M
Cash Flow
Free Cash Flow4.33M4.82M1.61M9.65M6.45M16.55M
Operating Cash Flow4.63M5.11M4.40M10.36M7.22M18.59M
Investing Cash Flow49.50K184.00K-2.59M-707.00K-772.00K-2.40M
Financing Cash Flow-10.51M-8.67M-11.00K-9.53M-11.56M-11.70M

MediNet Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.60
Price Trends
50DMA
0.52
Positive
100DMA
0.56
Negative
200DMA
0.52
Positive
Market Momentum
MACD
<0.01
Positive
RSI
54.28
Neutral
STOCH
23.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8161, the sentiment is Positive. The current price of 0.6 is above the 20-day moving average (MA) of 0.54, above the 50-day MA of 0.52, and above the 200-day MA of 0.52, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 54.28 is Neutral, neither overbought nor oversold. The STOCH value of 23.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8161.

MediNet Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
HK$160.98M5.316.92%8.00%-21.50%-43.25%
58
Neutral
HK$56.73M362.73-19.93%-2.91%55.41%
53
Neutral
HK$22.46M-197.60138.68%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
HK$84.86M-4.87-27.01%-11.68%-71.01%
42
Neutral
HK$124.00M-20.58-573.79%-30.45%-734.38%
41
Neutral
HK$16.65M-2.2926.12%14.64%-81.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8161
MediNet Group Ltd.
0.54
0.20
58.82%
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
100.00%
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.15
-27.27%
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-4.67%
HK:8357
Republic Healthcare Limited
0.14
0.07
91.55%
HK:8437
RMH Holdings Limited
0.25
0.08
47.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026